Bardin Hill Management Partners’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bardin Hill Management Partners’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-66,085	Closed	-$1.32M	–	117
2022 Q3	$1.32M	Buy	+66,085	New	+$872K	0.3%	38

Bardin Hill Management Partners's FMTX Position: Q4 2022 in Review

Bardin Hill Management Partners sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 66,085 shares — an estimated $1.32M sold.

Bardin Hill Management Partners first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $1.32M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Bardin Hill Management Partners reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Bardin Hill Management Partners sold 66,085 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $1.32M.
Bardin Hill Management Partners first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Bardin Hill Management Partners's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.32M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Bardin Hill Management Partners's 13F filing for Q4 2022, filed 14 Feb 2023.